SSH - LEXINGTON INC — History
CCN 182003 | 3-year financial timeline | COVID resilience: 60/100
🛡️ Public data only — no PHI permitted on this instance.
$14M
Latest Revenue (FY2022)
+3.6%
Revenue CAGR (3yr)
-0.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $13M | $13M | $14M | +10.5% | +3.6% |
| Operating Expenses | $14M | $15M | $14M | -2.6% | +1.8% |
| Operating Margin | -3.7% | -13.6% | -0.1% | +99.5% | +0.0% |
| Net Income | $-0M | $-2M | $-0M | +99.5% | +0.0% |
| Licensed Beds | 30 | 30 | 30 | +0.0% | +0.0% |
| Total Patient Days | 7,454 | 6,416 | 7,948 | +23.9% | +3.3% |
| Medicare Day % | 45% | 31% | 39% | +26.3% | -7.5% |
| Medicaid Day % | 4% | 5% | 1% | -84.9% | -57.3% |
COVID Impact & Recovery
Resilience Score: 60/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +7.3% ($13M → $14M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+3.6%
This Hospital
+7.6%
State Avg
Latest Margin
-0.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $15M | 1.7% |
| FY2024 (proj) | $15M | 3.5% |
| FY2025 (proj) | $16M | 5.4% |